Research ArticleArticle
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, Alfredo Guillén-Del-Castillo, Mayka Freire, Jose Antonio Vargas-Hitos, Jose Antonio Todolí-Parra, Mónica Rodríguez-Carballeira, Adela Marín-Ballvé, Gerard Espinosa, Dolores Colunga-Argüelles, Norberto Ortego-Centeno, Luis Trapiella-Martínez, Cristina Carbonell-Muñoz, Xavier Pla-Salas, Isabel Perales-Fraile, Xavier Corbella, Vicent Fonollosa-Pla and Carmen Pilar Simeón-Aznar for the RESCLE investigators, Autoimmune Diseases Study Group (GEAS)
The Journal of Rheumatology February 2019, jrheum.180595; DOI: https://doi.org/10.3899/jrheum.180595
Melani Pestaña-Fernández
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Manuel Rubio-Rivas
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Carles Tolosa-Vilella
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Alfredo Guillén-Del-Castillo
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Mayka Freire
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Jose Antonio Vargas-Hitos
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Jose Antonio Todolí-Parra
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Mónica Rodríguez-Carballeira
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Adela Marín-Ballvé
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Gerard Espinosa
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Dolores Colunga-Argüelles
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Norberto Ortego-Centeno
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Luis Trapiella-Martínez
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Cristina Carbonell-Muñoz
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Xavier Pla-Salas
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Isabel Perales-Fraile
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Xavier Corbella
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Vicent Fonollosa-Pla
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Carmen Pilar Simeón-Aznar
From the Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona; Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí, Sabadell, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron, Barcelona; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia; Department of Internal Medicine, Hospital Universitario Mútua Terrassa, Terrassa, Barcelona; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, Zaragoza; Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic, Barcelona; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada, Granada; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca, Salamanca; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona; Department of Internal Medicine, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid; Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain. This project was possible thanks to an unrestricted educational scholarship granted by Laboratorios Actelion. M. Pestaña-Fernández, MD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; M. Rubio-Rivas, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat; C. Tolosa-Vilella, MD, PhD, Department of Internal Medicine, Corporación Sanitaria Universitaria Parc Taulí; A. Guillén-Del-Castillo, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; M. Freire, MD, PhD, Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo; J.A. Vargas-Hitos, MD, PhD, Department of Internal Medicine, Hospital Universitario Virgen de las Nieves; J.A. Todolí-Parra, MD, Department of Internal Medicine, Hospital Universitario y Politécnico La Fe; M. Rodríguez Carballeira, MD, PhD, Department of Internal Medicine, Hospital Universitario Mútua Terrassa; A. Marín-Ballvé, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa; G. Espinosa, MD, PhD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Universitario Clinic; D. Colunga-Argüelles, MD, Department of Internal Medicine, Hospital Universitario Central de Asturias; N. Ortego-Centeno, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital Campus de la Salud, Complejo Universitario de Granada; L. Trapiella-Martínez, MD, PhD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes; C. Carbonell-Muñoz, MD, Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca; X. Pla-Salas, MD, Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic; I. Perales-Fraile, MD, Department of Internal Medicine, Hospital Universitario Rey Juan Carlos; X. Corbella, MD, PhD, Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital, L’Hospitalet de Llobregat, and Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya; V. Fonollosa-Pla, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron; C.P. Simeón Aznar, MD, PhD, Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d’Hebron. Address correspondence to Dr. M. Pestaña-Fernández, Bellvitge University Hospital, Department of Internal Medicine, Feixa Llarga, s/n, 08907 L’Hospitalet de Llobregat, Barcelona, Spain. E-mail: Melani.Pestana@sanitatintegral.org. Accepted for publication January 25, 2019.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, Alfredo Guillén-Del-Castillo, Mayka Freire, Jose Antonio Vargas-Hitos, Jose Antonio Todolí-Parra, Mónica Rodríguez-Carballeira, Adela Marín-Ballvé, Gerard Espinosa, Dolores Colunga-Argüelles, Norberto Ortego-Centeno, Luis Trapiella-Martínez, Cristina Carbonell-Muñoz, Xavier Pla-Salas, Isabel Perales-Fraile, Xavier Corbella, Vicent Fonollosa-Pla, Carmen Pilar Simeón-Aznar
The Journal of Rheumatology Feb 2019, jrheum.180595; DOI: 10.3899/jrheum.180595
Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study
Melani Pestaña-Fernández, Manuel Rubio-Rivas, Carles Tolosa-Vilella, Alfredo Guillén-Del-Castillo, Mayka Freire, Jose Antonio Vargas-Hitos, Jose Antonio Todolí-Parra, Mónica Rodríguez-Carballeira, Adela Marín-Ballvé, Gerard Espinosa, Dolores Colunga-Argüelles, Norberto Ortego-Centeno, Luis Trapiella-Martínez, Cristina Carbonell-Muñoz, Xavier Pla-Salas, Isabel Perales-Fraile, Xavier Corbella, Vicent Fonollosa-Pla, Carmen Pilar Simeón-Aznar
The Journal of Rheumatology Feb 2019, jrheum.180595; DOI: 10.3899/jrheum.180595